| 康宁杰瑞制药-B |
Pacific Alliance Group Limited |
减持 |
-9691190 |
4000.00万股 |
0.04% |
好仓 |
2020-06-16 |
| 康宁杰瑞制药-B |
PAG Growth I (BVI) Limited |
减持 |
-9691190 |
4000.00万股 |
0.04% |
好仓 |
2020-06-16 |
| 康宁杰瑞制药-B |
PAG Growth I LP |
减持 |
-9691190 |
4000.00万股 |
0.04% |
好仓 |
2020-06-16 |
| 康宁杰瑞制药-B |
PAG Growth Capital GP I Limited |
减持 |
-9691190 |
4000.00万股 |
0.04% |
好仓 |
2020-06-16 |
| 康宁杰瑞制药-B |
PAG Growth Limited |
减持 |
-9691190 |
4000.00万股 |
0.04% |
好仓 |
2020-06-16 |
| 康宁杰瑞制药-B |
Roseworth Investments Limited |
减持 |
-9691190 |
4000.00万股 |
0.04% |
好仓 |
2020-06-16 |
| 康宁杰瑞制药-B |
单伟建 |
减持 |
-9691190 |
4000.00万股 |
0.04% |
好仓 |
2020-06-16 |
| 康宁杰瑞制药-B |
PAG Holdings Limited |
减持 |
-9691190 |
4000.00万股 |
0.04% |
好仓 |
2020-06-16 |
| 三宝科技 |
China Cinda Asset Management Co., Ltd. |
减持 |
-38817864 |
0.00万股 |
0.00% |
好仓 |
2020-06-16 |
| 三宝科技 |
Cinda Asset Management (Cayman) Limited |
减持 |
-38817864 |
0.00万股 |
0.00% |
好仓 |
2020-06-16 |
| 三宝科技 |
Cinda Securities Co., Ltd. |
减持 |
-38817864 |
0.00万股 |
0.00% |
好仓 |
2020-06-16 |
| 三宝科技 |
Cinda International Holdings Limited |
减持 |
-38817864 |
0.00万股 |
0.00% |
好仓 |
2020-06-16 |
| 三宝科技 |
Pengda Value Fund SPC (acting for and on behalf of DTC SP) |
减持 |
-38817864 |
0.00万股 |
0.00% |
好仓 |
2020-06-16 |
| 建业地产 |
PAG Asia Loan Fund III L.P. |
减持 |
-143200000 |
0.00万股 |
0.00% |
好仓 |
2020-06-16 |
| 建业地产 |
PAG Asia Loan GP III Limited |
减持 |
-143200000 |
0.00万股 |
0.00% |
好仓 |
2020-06-16 |
| 建业地产 |
PAG Asia Loan LLC |
减持 |
-143200000 |
0.00万股 |
0.00% |
好仓 |
2020-06-16 |
| 建业地产 |
Pacific Alliance Group Limited |
减持 |
-143200000 |
0.00万股 |
0.00% |
好仓 |
2020-06-16 |
| 建业地产 |
PAG Holdings Limited |
减持 |
-143200000 |
0.00万股 |
0.00% |
好仓 |
2020-06-16 |
| 建业地产 |
Long Growth Opportunity VI Limited |
减持 |
-143200000 |
0.00万股 |
0.00% |
好仓 |
2020-06-16 |
| 春立医疗 |
Morgan Stanley |
增持 |
1067965 |
630.40万股 |
0.07% |
好仓 |
2020-06-16 |
